ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $669,000 | -21.3% | 16,411 | -12.5% | 0.03% | -27.3% |
Q4 2020 | $850,000 | +23.4% | 18,755 | -2.6% | 0.04% | +12.8% |
Q3 2020 | $689,000 | -1.1% | 19,253 | +4.3% | 0.04% | -7.1% |
Q2 2020 | $697,000 | +35.3% | 18,461 | +3.7% | 0.04% | +13.5% |
Q1 2020 | $515,000 | -42.8% | 17,807 | +2.5% | 0.04% | -27.5% |
Q4 2019 | $900,000 | -13.2% | 17,370 | -8.1% | 0.05% | -23.9% |
Q3 2019 | $1,037,000 | +70.8% | 18,895 | +26.4% | 0.07% | +81.1% |
Q2 2019 | $607,000 | +57.7% | 14,950 | +17.4% | 0.04% | +54.2% |
Q1 2019 | $385,000 | +19.2% | 12,737 | +32.7% | 0.02% | +4.3% |
Q4 2018 | $323,000 | -51.2% | 9,600 | -38.8% | 0.02% | -41.0% |
Q3 2018 | $662,000 | +32.4% | 15,689 | +0.3% | 0.04% | +21.9% |
Q2 2018 | $500,000 | -53.8% | 15,642 | -28.2% | 0.03% | -54.3% |
Q1 2018 | $1,083,000 | -3.0% | 21,780 | +5.2% | 0.07% | -1.4% |
Q4 2017 | $1,117,000 | +5.5% | 20,708 | +13.4% | 0.07% | +2.9% |
Q3 2017 | $1,059,000 | +42.9% | 18,257 | +21.5% | 0.07% | +40.8% |
Q2 2017 | $741,000 | +108.7% | 15,030 | +83.8% | 0.05% | +104.2% |
Q1 2017 | $355,000 | – | 8,178 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |